Genetics of spontaneous clearance of hepatitis C virus infection: A complex topic with much to learn

Authors


  • Potential conflict of interest: J.G. is a consultant/advisor and has received research grants from AbbVie, Bristol-Myers Squibb, Gilead, and Merck. G.D. is a consultant/advisor and has received research grants from AbbVie, Bristol-Myers Squibb, Gilead, Merck, Janssen, and Roche. He is on the speakers' bureau of Merck and Roche. A.Y.K. has served a consultant advisor and/or has received research grants from AbbVie, Gilead, and Bristol-Myers Squibb. M.P. is on the speakers' bureau for Roche and MSD.

No abstract is available for this article.

Ancillary